Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

Akcea steals march on Alnylam with NICE approval

Akcea steals march on Alnylam with NICE approval

Advantage to Tegsedi over Onpattro. NICE has recommended Akcea Therapeutics’ rare disease treatment Tegsedi (inotersen), after the company improved its price offer. ... NICE’s ruling adds to the good news for Akcea, which in March gained a CHMP

Latest news

More from news
Approximately 363 fully matching, plus 773 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 11 fully matching, plus 106 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest from PMHub

  • Mixing up Focus Groups

    A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and ... A ‘golden rule’ for organising focus groups – ensure a nice spread of homogeneous

  • Happy Hearts

    When I finally did meet a nice chap  ̶  i.e. nice enough to introduce to one’s mother, nice enough to be seen in public with, nice enough to talk ... to friends about without lying, and nice enough to be one’s self with, I said to him pretty

  • Artificial Intelligence in Healthcare

    enough for you, the National Institute for Health and Care Excellence (NICE) has approved the use of ‘AliveCor’, which is a mobile heart monitor that can detect, monitor, and manage atrial

  • Apple Watch Series 4: A life-saving tool or just making us more health obsessed?

    Something therefore tells me that NICE (The National Institute for Health and Clinical Excellence) won’t be approving the Apple Watch Series 4 as a medically approved device any time soon,

  • Solaris Health looks at the gene therapy revolution

    Agency), licensed in 2016 and approved by NICE (National Institute for Health and Care Excellence) earlier this year, the patients are young children, suffering from a severe dysfunction of the immune

More from PMHub
Approximately 4 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics